ArticleBritish journal of haematology2022

Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.

Jon Riise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.